Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms.

Astiarraga B, Gastaldelli A, Muscelli E, Baldi S, Camastra S, Mari A, Papadia F, Camerini G, Adami G, Scopinaro N, Ferrannini E.

J Clin Endocrinol Metab. 2013 Jul;98(7):2765-73. doi: 10.1210/jc.2013-1476. Epub 2013 May 10.

PMID:
23666972
2.

The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery.

Nannipieri M, Mari A, Anselmino M, Baldi S, Barsotti E, Guarino D, Camastra S, Bellini R, Berta RD, Ferrannini E.

J Clin Endocrinol Metab. 2011 Sep;96(9):E1372-9. doi: 10.1210/jc.2011-0446. Epub 2011 Jul 21.

PMID:
21778221
3.

β-Cell function improvements in grade I/II obese subjects with type 2 diabetes 1 month after biliopancreatic diversion: results from modeling analyses of oral glucose tolerance tests and hyperglycemic clamp studies.

Junqueira Vasques AC, Pareja JC, de Oliveira Mda S, Satake Novaes F, Miranda de Oliveira Lima M, Chaim ÉA, Piccinini F, Dalla Man C, Cobelli C, Geloneze B.

Diabetes Care. 2013 Dec;36(12):4117-24. doi: 10.2337/dc13-0530. Epub 2013 Oct 17.

4.

Long-term clinical and functional impact of biliopancreatic diversion on type 2 diabetes in morbidly and non-morbidly obese patients.

Scopinaro N, Camerini G, Papadia F, Andraghetti G, Cordera R, Adami GF.

Surg Obes Relat Dis. 2016 May;12(4):822-827. doi: 10.1016/j.soard.2015.12.011. Epub 2015 Dec 10.

PMID:
26947789
5.

Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes.

Gastaldelli A, Casolaro A, Pettiti M, Nannipieri M, Ciociaro D, Frascerra S, Buzzigoli E, Baldi S, Mari A, Ferrannini E.

Clin Pharmacol Ther. 2007 Feb;81(2):205-12.

PMID:
17259945
6.

Beta-cell function improvement after biliopancreatic diversion in subjects with type 2 diabetes and morbid obesity.

Briatore L, Salani B, Andraghetti G, Maggi D, Adami GF, Scopinaro N, Cordera R.

Obesity (Silver Spring). 2010 May;18(5):932-6. doi: 10.1038/oby.2010.28. Epub 2010 Feb 25.

7.

Hormone changes and diabetes resolution after biliopancreatic diversion and laparoscopic sleeve gastrectomy: a comparative prospective study.

Tsoli M, Chronaiou A, Kehagias I, Kalfarentzos F, Alexandrides TK.

Surg Obes Relat Dis. 2013 Sep-Oct;9(5):667-77. doi: 10.1016/j.soard.2012.12.006. Epub 2013 Jan 13.

PMID:
23466015
8.

Restoration of high-frequency glucose-entrained insulin oscillations in obese subjects with type 2 diabetes after biliopancreatic diversion.

Leonardou AS, Karystianos C, Argyropoulos C, Nikiforidis GC, Kalfarentzos F, Alexandrides TK.

Surg Obes Relat Dis. 2016 Sep - Oct;12(8):1539-1547. doi: 10.1016/j.soard.2016.04.009. Epub 2016 Apr 12.

PMID:
27425836
9.

Recovery of the incretin effect in type 2 diabetic patients after biliopancreatic diversion.

Novaes FS, Vasques AC, Pareja JC, Knop FK, Tura A, Chaim ÉA, Geloneze B.

J Clin Endocrinol Metab. 2015 May;100(5):1984-8. doi: 10.1210/jc.2014-4042. Epub 2015 Mar 5.

PMID:
25742514
10.

Improvement in insulin sensitivity and β-cell function following ileal interposition with sleeve gastrectomy in type 2 diabetic patients: potential mechanisms.

De Paula AL, Stival AR, Halpern A, DePaula CC, Mari A, Muscelli E, Vencio S, Ferrannini E.

J Gastrointest Surg. 2011 Aug;15(8):1344-53. doi: 10.1007/s11605-011-1550-6. Epub 2011 May 10.

PMID:
21557013
11.
12.

Bariatric surgery versus conventional medical therapy for type 2 diabetes.

Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G, Rubino F.

N Engl J Med. 2012 Apr 26;366(17):1577-85. doi: 10.1056/NEJMoa1200111. Epub 2012 Mar 26.

13.

Remission of type 2 diabetes mellitus should not be the foremost goal after bariatric surgery.

Ramos-Levi AM, Sanchez-Pernaute A, Cabrerizo L, Matia P, Barabash A, Hernandez C, Calle-Pascual AL, Torres AJ, Rubio MA.

Obes Surg. 2013 Dec;23(12):2020-5. doi: 10.1007/s11695-013-1032-x.

PMID:
23893315
14.

Long-Term Outcomes of Biliopancreatic Diversion on Glycemic Control, Insulin Sensitivity and Beta Cell Function.

Vasques AC, Pareja JC, da Saúde de Oliveira M, Novaes FS, Lima MM, Chaim ÉA, Piccinini F, Dalla Man C, Cobelli C, Geloneze B.

Obes Surg. 2016 Nov;26(11):2572-2580.

PMID:
27091049
15.

Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.

Nannipieri M, Baldi S, Mari A, Colligiani D, Guarino D, Camastra S, Barsotti E, Berta R, Moriconi D, Bellini R, Anselmino M, Ferrannini E.

J Clin Endocrinol Metab. 2013 Nov;98(11):4391-9. doi: 10.1210/jc.2013-2538. Epub 2013 Sep 20.

PMID:
24057293
16.

The long-term impact of biliopancreatic diversion on glycemic control in the severely obese with type 2 diabetes mellitus in relation to preoperative duration of diabetes.

Camerini GB, Papadia FS, Carlini F, Catalano M, Adami GF, Scopinaro N.

Surg Obes Relat Dis. 2016 Feb;12(2):345-9. doi: 10.1016/j.soard.2015.05.012. Epub 2015 May 28.

PMID:
26381876
17.

Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function.

Mari A, Manco M, Guidone C, Nanni G, Castagneto M, Mingrone G, Ferrannini E.

Diabetologia. 2006 Sep;49(9):2136-43. Epub 2006 Jul 4.

PMID:
16819611
18.

beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss.

Camastra S, Manco M, Mari A, Baldi S, Gastaldelli A, Greco AV, Mingrone G, Ferrannini E.

Diabetes. 2005 Aug;54(8):2382-9.

19.

Diagnosis of diabetes remission after bariatic surgery may be jeopardized by remission criteria and previous hypoglycemic treatment.

Ramos-Levi A, Sanchez-Pernaute A, Matia P, Cabrerizo L, Barabash A, Hernandez C, Calle-Pascual A, Torres A, Rubio M.

Obes Surg. 2013 Oct;23(10):1520-6. doi: 10.1007/s11695-013-0995-y.

PMID:
23702908
20.

Improved glycemic control enhances the incretin effect in patients with type 2 diabetes.

An Z, Prigeon RL, D'Alessio DA.

J Clin Endocrinol Metab. 2013 Dec;98(12):4702-8. doi: 10.1210/jc.2013-1199. Epub 2013 Oct 3.

PMID:
24092826

Supplemental Content

Support Center